Secondhand exposure to aerosol from electronic cigarettes: pilot study of assessment of tobacco-specific nitrosamine (NNAL) in urine

Mostra el registre complet Registre parcial de l'ítem

  • dc.contributor.author Martínez-Sánchez, Jose M.
  • dc.contributor.author Ballbé, Montse
  • dc.contributor.author Pérez Ortuño, Raúl, 1976-
  • dc.contributor.author Fu, Marcela
  • dc.contributor.author Sureda, Xisca
  • dc.contributor.author Pascual Esteban, José A.
  • dc.contributor.author Peruga, Armando
  • dc.contributor.author Fernández, Esteve
  • dc.date.accessioned 2019-07-24T07:37:51Z
  • dc.date.available 2019-07-24T07:37:51Z
  • dc.date.issued 2018
  • dc.description.abstract OBJECTIVE: To assess the levels of a tobacco-specific nitrosamine (NNAL) in non-smokers passively exposed to the second-hand aerosol (SHA) emitted from users of electronic cigarettes (e-cigarettes). METHOD: We conducted an observational study involving 55 non-smoking volunteers divided into three groups: 25 living at home with conventional smokers, 6 living with e-cigarette users, and 24 in control homes (smoke-free homes). We obtained urine samples from all volunteers to determine NNAL. RESULTS: We detected NNAL in the urine of volunteers exposed to e-cigarettes (median:0.55 pg/mL; interquartile range: 0.26-2.94 pg/mL). The percentage of urine samples with quantifiable NNAL differed significantly among the three groups of homes: 29.2%, 66.7% and 76.0%, respectively (p=0.004). CONCLUSIONS: We found NNAL nitrosamine in urine samples from people exposed to SHA from e-cigarettes. However, these results could be confirmed with more studies with larger sample sizes.
  • dc.format.mimetype application/pdf
  • dc.identifier.citation Martínez-Sánchez JM, Ballbè M, Pérez-Ortuño R, Fu M, Sureda X, Pascual JA et al. Secondhand exposure to aerosol from electronic cigarettes: pilot study of assessment of tobacco-specific nitrosamine (NNAL) in urine. Gac Sanit. 2019;33(6):575-8. DOI: 10.1016/j.gaceta.2018.07.016
  • dc.identifier.doi http://dx.doi.org/10.1016/j.gaceta.2018.07.016
  • dc.identifier.issn 0213-9111
  • dc.identifier.uri http://hdl.handle.net/10230/42155
  • dc.language.iso eng
  • dc.publisher Elsevier
  • dc.relation.ispartof Gaceta Sanitaria. 2019;33(6):575-8
  • dc.rights 0213-9111/© 2018 SESPAS. Publicado por Elsevier España, S.L.U. Este es un artículo Open Access bajo la licencia CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
  • dc.rights.accessRights info:eu-repo/semantics/embargoedAccess
  • dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/
  • dc.subject.keyword Biomarcadores
  • dc.subject.keyword Biomarkers
  • dc.subject.keyword Cigarrillo electrónico
  • dc.subject.keyword Electronic cigarette
  • dc.subject.keyword Nitrosaminas
  • dc.subject.keyword Nitrosamines
  • dc.subject.keyword Second-hand aerosol
  • dc.title Secondhand exposure to aerosol from electronic cigarettes: pilot study of assessment of tobacco-specific nitrosamine (NNAL) in urine
  • dc.type info:eu-repo/semantics/article
  • dc.type.version info:eu-repo/semantics/publishedVersion